The Independent

Ebola vaccine trial offers hope amid deadly DRC outbreak

A vaccine trial targeting the Ebola Bundibugyo virus in the Democratic Republic of the Congo (DRC) is expected to begin shortly, raising hopes for new tools to combat an outbreak that has killed ...

The real test for Moderna’s cancer vaccine isn’t about beating Keytruda. It’s keeping cancer from coming back in the long term.

The first Phase 3 data for a custom cancer vaccine has raised questions about whether the potential new treatment is needed.

Revelan los primeros resultados de una prometedora vacuna experimental contra el cáncer

Las vacunas personalizadas contra el cáncer avanzan con nuevas investigaciones. Merck & Co y Moderna estudian una terapia de ARN mensajero para pacientes con melanoma.

Phase II Results of Sacituzumab Tirumotecan (sac-TMT) plus Pembrolizumab in Advanced Urothelial Carcinoma Presented at 2026 ESMO

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech" or the "Company", 6990.HK) announced that at the 2026 ...
Fierce Biotech

‘It is what it is’: Merck exec unruffled by ‘unfortunate’ leak of ESMO cancer vaccine data

Merck & Co. and Moderna always knew they would be making headlines in Madrid this week—just not in the way it panned out. | Merck & Co. and Moderna always knew they would be making headlines in Madrid ...

Moderna's cancer vaccine is 'likely' to get approved. Skeptics question if it will be the best option.

The first Phase 3 data for a custom cancer vaccine has raised questions about whether the potential new treatment is needed Moderna's stock was down slightly Friday, after plunging 17.6% on Thursday.